Chemical compounds
US7115621B2 · kind B2 · utility
12Cited by
7References
39Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Apr 2, 2002 |
| Grant date | Oct 3, 2006 |
| Priority date | — |
| Expiry date | Jun 16, 2022 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P37/08
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Compounds of general structural formula (I) and use of the compounds and salts and solvates thereof, as therapeutic agents as inhibitors of phosphodiesterase 5 cardiovascular disorders
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.